Biodexa Pharmaceuticals Plc

BDRX chart

Biodexa Pharmaceuticals Plc news

• Biodexa Reports Serenta Trial Two-Thirds Enrolled, MTX240 Preparations Advance

  TipRanks · Nov 9, 8:57 AM EST

• Biodexa provides R&D Update

  Yahoo Finance · Nov 9, 8:30 AM EST

• A trial for an inherited colon-polyp condition could reach an early checkpoint in 2027.

  Stock Titan · Nov 9, 8:30 AM EST

• Price to book ratio of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP3

  TradingView · Nov 8, 9:29 PM EST

• Diluted net income available to common stockholders of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP3

  TradingView · Nov 8, 7:08 PM EST

• Biodexa Pharmaceuticals Plc (5MP3.F) Seasonal returns chart - Yahoo Finance

  Yahoo Finance Singapore · Nov 7, 10:12 AM EST

• Biodexa Pharmaceuticals Plc (5MP3.F) cash flow – Yahoo Finance

  Yahoo Finance Singapore · Nov 6, 3:44 PM EST

• European Equities Traded in the US as American Depositary Receipts Advance Sharply in Wednesday Trading

  Yahoo Finance · Nov 4, 11:13 AM EST

• Short Interest Alert: Most and least shorted sub-$2B healthcare stock at the end of October

  Seeking Alpha · Nov 3, 10:15 AM EST

• European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

  Yahoo Finance · Oct 14, 11:10 AM EDT

• Biodexa Reaches 100-Patient Enrollment Milestone in Phase 3 Serenta Trial as Key Analysis Timeline Accelerates

  investorshub.advfn.com · Oct 13, 9:51 AM EDT

• Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP

  Yahoo Finance · Oct 13, 8:30 AM EDT

Biodexa Pharmaceuticals Plc key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-11-09
• 6-KFORM 6-K2026-10-14
• 6-KReport (foreign issuer)2026-10-08
• 6-KReport (foreign issuer)2026-09-15
• 6-KReport (foreign issuer)2026-09-11
• 6-KReport (foreign issuer)2026-07-29
• 6-KReport (foreign issuer)2026-07-09
• 6-KFORM 6-K2026-06-30
• 6-KReport (foreign issuer)2026-06-30
• 6-KReport (foreign issuer)2026-06-17
• 6-KReport (foreign issuer)2026-05-14
• 20-FAnnual report (foreign issuer)2026-03-27

About Biodexa Pharmaceuticals Plc

Ticker

BDRX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Cardiff

Incorporated in

United Kingdom

Fiscal year end

December 31

SEC CIK

1643918

Former names

Midatech Pharma Plc

Frequently asked questions